ISIN | LU2215385449 |
---|---|
Valorennummer | 56442999 |
Bloomberg Global ID | MUFOHEH LX |
Fondsname | Multi Manager Access II - Future of Humans EUR-hedged Q-acc |
Fondsanbieter |
UBS Switzerland AG, Zurich
Basel, Schweiz Telefon: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fondsanbieter | UBS Switzerland AG, Zurich |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Anlagekategorie | Andere Fonds |
EFC-Kategorie | Equity Global |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Ausgabekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Konditionen bei der Rücknahme | Rücknahmekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Investment-Strategie *** | The investment objective of the actively managed sub-fund is to seek long-term real returns. No guarantee can be given that this investment objective will be achieved. The sub-fund is categorized as an ESG Integrated Fund. However, the sub-fund does not promote particular ESG characteristics or pursue a specific sustainability or impact objective. The investments underlying this financial product do not take into account the EU criteria for environmentally sustainable economic activities. |
Besonderheiten |
Aktueller Preis * | 93.61 EUR | 19.09.2024 |
---|---|---|
Vorheriger Preis * | 92.28 EUR | 18.09.2024 |
52 Wochen Hoch * | 93.61 EUR | 19.09.2024 |
52 Wochen Tief * | 75.58 EUR | 27.10.2023 |
NAV * | 93.61 EUR | 19.09.2024 |
Ausgabepreis * | 93.61 EUR | 19.09.2024 |
Rücknahmepreis * | 93.61 EUR | 19.09.2024 |
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 58'273'267 | |
Anteilsklassevermögen *** | 4'030'488 | |
Trading Information SIX |
YTD-Performance | +7.62% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
---|---|---|
YTD-Performance (in CHF) | +9.62% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
1 Monat | +2.27% |
19.08.2024 - 19.09.2024
19.08.2024 19.09.2024 |
3 Monate | +4.80% |
20.06.2024 - 19.09.2024
20.06.2024 19.09.2024 |
6 Monate | +4.30% |
19.03.2024 - 19.09.2024
19.03.2024 19.09.2024 |
1 Jahr | +13.96% |
19.09.2023 - 19.09.2024
19.09.2023 19.09.2024 |
2 Jahre | +15.65% |
19.09.2022 - 19.09.2024
19.09.2022 19.09.2024 |
3 Jahre | -18.96% |
20.09.2021 - 19.09.2024
20.09.2021 19.09.2024 |
5 Jahre | -6.39% |
19.10.2020 - 19.09.2024
19.10.2020 19.09.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk A/S Class B | 3.09% | |
---|---|---|
UnitedHealth Group Inc | 2.61% | |
Boston Scientific Corp | 2.50% | |
AstraZeneca PLC | 2.45% | |
Eli Lilly and Co | 2.29% | |
Danaher Corp | 1.92% | |
Bristol-Myers Squibb Co | 1.83% | |
Netflix Inc | 1.81% | |
Roche Holding AG | 1.77% | |
Amazon.com Inc | 1.75% | |
Letzte Daten-Aktualisierung | 31.08.2024 |
TER | 1.05% |
---|---|
Datum TER | 31.07.2023 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.77% |
Ongoing Charges *** | 1.01% |
SRRI ***
|
|
Datum SRRI *** |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |